Nationwide Geographic Access to Subcutaneous Anti-Amyloid Alzheimer Disease Therapy Infrastructure
JAMA Neurology · 16.11.2026
DOI: 10.1001/jamaneurol.2026.4253 ↗Kurz gefasst
Fachartikel in der Zeitschrift JAMA Neurology, online erschienen am 16.11.2026. Verfasst von Fred B Ketchum und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, University of Wisconsin School of Medicine and Public Health, Madison. Die Arbeit nennt 10 Literaturangaben.
Themen: Demenz
Abstract (Originalsprache)
This cross-sectional study describes how geographic availability of the minimum health care infrastructure required for subcutaneous therapy for Alzheimer disease treatment varies by age and location across the US.
Autor:innen und Institutionen
- Department of Neurology, University of Wisconsin School of Medicine and Public Health, Madison.
- Center for Heath Disparities Research, University of Wisconsin School of Medicine and Public Health, Madison.
- Department of Medicine, Geriatrics Division, University of Wisconsin School of Medicine and Public Health, Madison.
- Wisconsin Alzheimer's Disease Research Center, University of Wisconsin School of Medicine and Public Health, Madison.
Zitieren
APA
Ketchum, F. B., Sanford, C., Buckingham, W., Kind, A. J. H., & Powell, W. R. (2026). Nationwide Geographic Access to Subcutaneous Anti-Amyloid Alzheimer Disease Therapy Infrastructure. JAMA Neurology. https://doi.org/10.1001/jamaneurol.2026.4253
Vancouver
Ketchum FB, Sanford C, Buckingham W, Kind AJH, Powell WR. Nationwide Geographic Access to Subcutaneous Anti-Amyloid Alzheimer Disease Therapy Infrastructure. JAMA Neurology. 2026. doi:10.1001/jamaneurol.2026.4253
BibTeX
@article{Ketchum2026,
author = {Ketchum, Fred B and Sanford, Cassie and Buckingham, Will and Kind, Amy J H and Powell, W Ryan},
title = {Nationwide Geographic Access to Subcutaneous Anti-Amyloid Alzheimer Disease Therapy Infrastructure},
journal = {JAMA Neurology},
year = {2026},
doi = {10.1001/jamaneurol.2026.4253}
}
EUVIMED